Department of Advanced Renal Sciences

URO-ONCOLOGY

PROSTATE CANCER PROGRAM (Complete Spectrum From Diagnosis To Treatment)

PSA screening has induced a significant downward migration in age and stage (both clinical and pathologic) at diagnosis. Early prostate cancer can be cured surgically

ADVANCED DIAGNOSIS:

TRUS (Trans Rectal Ultrasound) TRUS Biopsy

(Trans Rectal Ultrasound Guided Biopsy)

  • Biplanar probe for accurate diagnosis
  • Increases grade concordance
  • Frozen Section

MPMRI | PET Scan | Nuclear Scan
(Whole body scan, bone scan)

ADVANCED TREATMENT:

Localized Prostate Cancer

(Trans Rectal Ultrasound Guided Biopsy)

  • Laparoscopic Radical Prostatectomy
  • IGRT (Conformal Radiation)

Results: 100% disease specific survival rate@ 5 years

Localized Advanced Prostate Cancer

  • Trimodal therapy
    Surgery | Radiation therapy | CAB
  • Brachytherapy

Metastatic prostate cancer clinic

  • Bone management
  • Obstructive uropathy management
  • Anemia management
  • CRPC management


BLADDER CANCER PROGRAM


Bladder cancer is related to age and exposure to environmental carcinogens, primarily smoking.

  • The median age of bladder cancer diagnosis is 70 years for men and women.
  • Smoking is the most common cause of urothelial cancer
  • A diet rich in fruits and vegetables is protective against bladder cancer formation

NMIBC (Non Muscle Invasive Bladder Cancer)

  • Flexible Cystoscopy
  • Intravesical Immunotherapy
  • Intravesical Chemotherapy
  • Narrow Band Therapy
  • TURBT

MIBC (Muscle Invasive Bladder Cancer)

  • Laparoscopic Radical Cystectomy
  • Male/Female
  • Neobladder
  • Illeal Conduit

MULTIMODALITY TREATMENT
(all at single health care facility)

  • Surgery
  • Radiotherapy
  • Chemotherapy

WE FOLLOW NCCN GUIDLINES


KIDNEY CANCER


Renal cell carcinoma (RCC) is a Kidney cancer that originates in the very small tubes in the kidney that transport waste molecules from the blood to the urine. RCC is the most common type of kidney cancer in adults, responsible for approximately 90–95% of cases.

Initial treatment is most commonly either partial or complete removal of the affected kidney(s). Where the cancer has not metastasised (spread to other organs) or burrowed deeper into the tissues of the kidney, (i.e. stage I & stage II cancer) the 5-year survival rate is above 90%, but this is lowered considerably when the cancer has spread. Presentation may be incidental, abdominal mass, flank pain or hematuria.

Laparoscopic Radical Nephrectomy is the standard of care.

  • Smaller skin incision - four 1 cm incisions rather than a 30 cm incision.
  • Less blood loss and reduced need for a blood transfusion.
  • Better view because of the magnification of the system.
  • Less pain because the incisions are smaller and the muscles are parted rather than cut
  • Early recovery, the ability to return to work in 2 to 4 weeks

KIDNEY CANCER IS CURABLE

Copyright© Patel Hospital 2018. All right reserved.